Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-17

FDA Approved: LEFLUNOMIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Leflunomide from Lupin Pharmaceuticals, Inc., indicating FDA approval of changes to this generic product (such a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

SUPPL AP for LEFLUNOMIDE (LEFLUNOMIDE)